Top 5 Takeaways New Vaccine Approval: The FDA has approved the Pfizer Pentavalent Meningococcal Vaccine (MenACWY-TT/MenB-FHbp, branded as Penbraya) for individuals aged 10–25 years to protect against serogroups A, B,

Top 5 Takeaways High Infection and Hospitalization Rates: Throughout the study period, SARS-CoV-2 infection rates ranged from 61.4 to 133.8 per 10,000 nursing home residents, with a peak of 133.8

Top 5 Takeaways Initial Vaccine Effectiveness: The original monovalent mRNA COVID-19 vaccine was 52% effective in preventing COVID-19-related hospitalization in children and adolescents when the last dose was received within

Top 5 Takeaways Reemergence of Poliovirus in Malawi: Despite the WHO’s declaration in 2020 that the African Region was free from wild poliovirus, a case was confirmed in Malawi in

Top 5 Takeaways Disproportionately Higher COVID-19 Impact on AI/AN Persons: AI/AN individuals in Alaska experienced COVID-19 illness, hospitalization, and death rates approximately 2 to 3 times higher than White persons

Top 5 Takeaways Initial Disparities in Vaccination Coverage: Early in the vaccination campaign, Asian and non-Hispanic White adults had the highest COVID-19 vaccination coverage, while coverage was lower among Hispanic,

Top 5 Takeaways Low incidence of sudden cardiac death post-vaccination: Among 1,292 deaths of Oregon residents aged 16–30 during the study period, only three sudden deaths occurred within 100 days